1. Home
  2. ACET vs RVSB Comparison

ACET vs RVSB Comparison

Compare ACET & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACET
  • RVSB
  • Stock Information
  • Founded
  • ACET 1947
  • RVSB 1923
  • Country
  • ACET United States
  • RVSB United States
  • Employees
  • ACET N/A
  • RVSB N/A
  • Industry
  • ACET Biotechnology: Pharmaceutical Preparations
  • RVSB Savings Institutions
  • Sector
  • ACET Health Care
  • RVSB Finance
  • Exchange
  • ACET Nasdaq
  • RVSB Nasdaq
  • Market Cap
  • ACET 111.9M
  • RVSB 110.2M
  • IPO Year
  • ACET N/A
  • RVSB 1993
  • Fundamental
  • Price
  • ACET $0.58
  • RVSB $5.25
  • Analyst Decision
  • ACET Buy
  • RVSB Buy
  • Analyst Count
  • ACET 4
  • RVSB 1
  • Target Price
  • ACET $8.50
  • RVSB $7.00
  • AVG Volume (30 Days)
  • ACET 1.8M
  • RVSB 42.0K
  • Earning Date
  • ACET 11-05-2025
  • RVSB 10-28-2025
  • Dividend Yield
  • ACET N/A
  • RVSB 1.52%
  • EPS Growth
  • ACET N/A
  • RVSB 361.12
  • EPS
  • ACET N/A
  • RVSB 0.22
  • Revenue
  • ACET N/A
  • RVSB $52,756,000.00
  • Revenue This Year
  • ACET N/A
  • RVSB $10.25
  • Revenue Next Year
  • ACET N/A
  • RVSB $11.23
  • P/E Ratio
  • ACET N/A
  • RVSB $23.87
  • Revenue Growth
  • ACET N/A
  • RVSB 15.20
  • 52 Week Low
  • ACET $0.45
  • RVSB $4.74
  • 52 Week High
  • ACET $1.19
  • RVSB $6.59
  • Technical
  • Relative Strength Index (RSI)
  • ACET 36.18
  • RVSB 51.54
  • Support Level
  • ACET $0.57
  • RVSB $5.05
  • Resistance Level
  • ACET $0.67
  • RVSB $5.34
  • Average True Range (ATR)
  • ACET 0.06
  • RVSB 0.14
  • MACD
  • ACET 0.00
  • RVSB -0.01
  • Stochastic Oscillator
  • ACET 26.97
  • RVSB 40.01

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

Share on Social Networks: